Optimizing Therapy for Patients with Hormone Receptor (HR)-Positive Localized Breast Cancer — July 24, 2026, Houston, TX

A CME/MOC-Accredited Interactive Grand Rounds Series

Date
Friday, July 24, 2026

Program Schedule — Central Time
11:30 AM – 12:00 PM — Registration and Lunch
12:00 PM – 1:00 PM — Educational Program

Location
Houston Methodist Hospital
6445 Main Street
Houston, TX 77030

Meeting Room
OPC 24th Floor Room 316

Faculty

Adam M Brufsky

MD, PhD

UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania

Professor of Medicine, Department of Medicine

Registration

This activity is intended for hematologists, medical oncologists, hematology-oncology fellows and other healthcare providers involved in the treatment of breast cancer.

I am a:

Clinician / healthcare professional

Other / industry professional

Name(Required)

First Last

Email(Required)

Address(Required)

City State / Province / Region Country

Degree(Required)

Specialty(Required)

If you are a clinician, which of the following best describes your practice setting?(Required)

National Provider Identifier (NPI) Number

These activities are supported by educational grants from Biotheranostics Inc, A Hologic Company, Exact Sciences Corporation, Lilly, and Novartis.